Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Kolind S, Gaetano L, Assemlal HE, Bernasconi C, et al. Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Mult Scler 2023;29:741-747.
PMID: 37148240


Privacy Policy